ALR : Summary for Alere Inc. - Yahoo Finance

U.S. Markets closed

Alere Inc. (ALR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
49.17+0.07 (+0.14%)
At close: 4:02PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close49.10
Bid48.99 x 500
Ask49.25 x 100
Day's Range49.06 - 49.24
52 Week Range31.47 - 49.42
Avg. Volume1,352,828
Market Cap4.28B
PE Ratio (TTM)-70.14
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire4 days ago

    Alere Launches the Alere™ Malaria Ag P.f, the First-Ever Rapid Test to Screen Malaria Infection in Asymptomatic Individuals

    WALTHAM, Mass., April 25, 2017 /PRNewswire/ -- Alere Inc. (ALR), a global leader in rapid diagnostics, today announced the launch of its Alere™ Malaria Ag P.f, a major technological breakthrough in high-sensitivity rapid testing versus currently available malaria RDTs (rapid diagnostic tests). The Alere Malaria Ag P.f offers a greater than tenfold improvement in the detection of histidine rich protein II (HRP-II) antigen of Plasmodium falciparum, which will enable better identification of individuals with very low parasitemia, many of whom may be without evident symptoms of malaria infection. This highly sensitive diagnostic will help healthcare workers screen individuals who are asymptomatic but may be carrying the parasite, and thus can aid the implementation of surveillance and mass screen-and-treat programs that are critical for accelerating malaria elimination.

  • Reuters9 days ago

    LPC: US healthcare lending rouses from policy-induced sedation

    US drug distributor Cardinal Health Inc’s deal to buy Medtronic Plc’s medical supplies units days after Abbott Laboratories agreed to a long-awaited purchase of diagnostic testing company Alere Inc has raised the pulse of a sector suppressed by potential healthcare policy upheaval. Highly anticipated tax reforms are being delayed by the ongoing healthcare policy debate.

  • TheStreet.com10 days ago

    Abbott CEO Upbeat Despite Ongoing Merger Headaches

    Troubles at a plant acquired with St. Jude and continuing risks to closing the Alere deal linger over M&A spree.